Earnings Call Insights: Merck & Co., Inc. (MRK) Q3 2026 Management View “We delivered solid performance with revenue of $18.1 billion, reflecting increased contributions from new products as well as strength in Oncology and Animal Health.” (Chairman, President & CEO Robert Davis)
Merck Outlines 2026 Revenue of $66.8b-$67.3b and EPS of $2.77-$2.82 While Investing Ahead of Keytruda LOE
Earnings Call Insights: Merck & Co., Inc. (MRK) Q3 2026 Management View "We delivered solid performance with revenue of $18.1 billion, reflecting increased contributions from new products as well as strength in Oncology and Animal Health." (Chairman, President & CEO Robert Davis)